Company / Revenue
Atea Pharmaceuticals, Inc. Revenue History
FY2020-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$48.6M
FY2021
5-year range
$48.6M / $48.6M
FY2020-FY2021
Trend
+0.0%
vs FY2020
Sector context
Sector data unavailable
Latest sector comparison
What the data says
$49M in FY2021.
Revenue over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2021, revenue increased 0.0% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 10.30 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | - | - |
| FY2021 | $48.6M | +0.0% |
| FY2020 | $48.6M | - |
As of FY2021 · SEC 10-K · Updated Jun 24, 2026